SCHEDULE 13G/A: BlackRock Maintains Significant Passive Stake in Alector Inc., Discloses 6.2% Beneficial Ownership

BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a 6.2% beneficial ownership stake in Alector Inc. as of March 31, 2025.

Summary

• BlackRock, Inc. filed an Amendment No. 4 to Schedule 13G concerning its beneficial ownership in Alector Inc. Common Stock.
• As of March 31, 2025, BlackRock, Inc. beneficially owns an aggregate of 6,116,564 shares of Alector Inc. Common Stock.
• This ownership represents 6.2% of the total class of securities outstanding.
• BlackRock, Inc. holds sole voting power over 6,072,747 shares and sole dispositive power over 6,116,564 shares.
• No shared voting or dispositive power is reported by BlackRock, Inc.
• The filing certifies that the securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing the control of Alector Inc.
• Several BlackRock subsidiaries, including BlackRock Advisors, LLC, BlackRock Asset Management Canada Limited, BlackRock (Netherlands) B.V., BlackRock Fund Advisors, BlackRock Asset Management Ireland Limited, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., and BlackRock Investment Management, LLC, are identified as entities that acquired the security.
• BlackRock Institutional Trust Company, National Association is specifically noted as beneficially owning 5% or greater of the outstanding shares of the security class.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing (Schedule 13G) indicating a passive ownership stake by a major institutional investor. While not directly positive or negative about the issuer's performance, the continued significant stake by BlackRock can be seen as a neutral to slightly positive signal of institutional confidence, without implying any active endorsement or strategic move.

Positives

• BlackRock, a prominent institutional investor, maintains a significant 6.2% stake in Alector Inc., indicating continued passive investment interest.
• The filing explicitly states that BlackRock's acquisition and holding of shares are in the ordinary course of business and not for the purpose of influencing control, which can provide stability to the issuer's corporate governance.

Future Outlook

This document is a historical ownership disclosure and does not contain forward-looking statements or guidance from Alector Inc. or BlackRock regarding Alector's future operations or financial performance.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a routine disclosure by a large asset manager, BlackRock, indicating its passive investment in Alector Inc., a biotechnology company. It reflects BlackRock's portfolio management activities rather than specific industry trends for Alector Inc. or the biotechnology sector.

Comparison to Industry Standards

• This is a standard Schedule 13G filing by a large institutional investor like BlackRock.
• The 6.2% stake is significant enough to require disclosure but is within typical passive investment ranges for large asset managers, which often hold stakes in numerous public companies as part of their diversified portfolios.
• The document does not provide specific financial or operational results for Alector Inc. that would allow for a direct comparison to global benchmarks or specific comparable companies/projects within the biotechnology industry.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, potentially offering some stability by indicating a passive, long-term investment intent from BlackRock.

Key Dates

Keywords

Alector Inc., BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Passive Investment, ALTO